EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Precise Control of the in vivo Fate of Nanomicelles Efficiently Treats Advanced Rheumatoid Arthritis via EGFR/JNK/MMP9 Pathway

Na Jia iD, Yunzhen Gao, Lan Yang, Yani Xu, Zhirong Zhang, Jingwen Wang iD, Ling Zhang iD

International Journal of Nanomedicine · 2025-04 · Volume 20 · 5353-5375

DOI: 10.2147/ijn.s511421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-04. Verfasst von Na Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, People's Republic of China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Förster resonance energy transfer (FRET) technology is a tool for in vivo nanomedicine tracking. Nanomicelle-based drug carriers could improve therapeutic outcome for rheumatoid arthritis (RA). Self-assembled nanomicelles are a major type of them, and their drug-loading stability is seriously affected by the in vivo environment. Therefore, it is critical to understand the status of nanomicelles in vivo at different time points, in order to enable precise control of their dynamics to effectively deliver the drug to inflammatory joint.

Methods

We applied FRET technology to elucidate the biofate of nanomicelles in an adjuvant induced arthritis (AIA) mice model and inflammatory larvae zebrafish models. We explored the molecular mechanism of swertiamarin-loaded nanomicelles (SWE-NMs) in improving RA symptoms through network pharmacology, molecular docking and immunofluorescence experiments.

Results

Results showed that on cellular level the nanomicelles could enter inflammatory cells and completely release most cargoes in 12 h, while in animals, the majority of nanomicelles was destroyed within 72 h. Hence, we tailored an administration scheme for RA treatment. As expected, we loaded swertiamarin into the nanomicelles (SWE-NMs). The injection every 3 days (SWE-NMs/3) displayed enhanced accumulation in arthritic joints and strong anti-RA therapeutic effect, as well as good safety profile. In addition, network pharmacology, molecular docking analysis and immunofluorescence experiments revealed that SWE-NMs might work by blocking the epidermal growth factor receptor/c-Jun N-terminal kinase/matrix metalloproteinase (EGFR/JNK/MMP9) pathway.

Conclusion

In summary, this study elucidated the biofate of nanomicelles with FRET technology in RA treatment, thus providing a basis for rationally improving administration scheme and giving clue for investigating other nano delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAnimalsMicellesZebrafishMiceErbB ReceptorsDrug CarriersMatrix Metalloproteinase 9Fluorescence Resonance Energy TransferArthritis, ExperimentalHumansMolecular Docking SimulationNanoparticlesMAP Kinase Signaling System

Stichwörter der Autor:innen

Förster resonance energy transferSwertimarinadvanced rheumatoid arthritisefficient treatmentin vivo fatenanomicelles

Substanzen

MicellesErbB ReceptorsDrug CarriersMatrix Metalloproteinase 9

Autor:innen und Institutionen

  • Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
  • Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Chengdu, 610041, People's Republic of China.
  • State Key Laboratory of Polymer Materials Engineering, College of Polymer Science and Engineering, Sichuan University, Chengdu, 610041, People's Republic of China.
  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

ORCID-Profile: Na Jia, Jingwen Wang, Ling Zhang

Zitieren

APA

Jia, N., Gao, Y., Yang, L., Xu, Y., Zhang, Z., Wang, J., & Zhang, L. (2025). Precise Control of the in vivo Fate of Nanomicelles Efficiently Treats Advanced Rheumatoid Arthritis via EGFR/JNK/MMP9 Pathway. International Journal of Nanomedicine, Volume 20, 5353-5375. https://doi.org/10.2147/ijn.s511421

Vancouver

Jia N, Gao Y, Yang L, Xu Y, Zhang Z, Wang J, et al. Precise Control of the in vivo Fate of Nanomicelles Efficiently Treats Advanced Rheumatoid Arthritis via EGFR/JNK/MMP9 Pathway. International Journal of Nanomedicine. 2025;Volume 20:5353-5375. doi:10.2147/ijn.s511421

BibTeX
@article{Jia2025,
  author = {Jia, Na and Gao, Yunzhen and Yang, Lan and Xu, Yani and Zhang, Zhirong and Wang, Jingwen and Zhang, Ling},
  title = {Precise Control of the in vivo Fate of Nanomicelles Efficiently Treats Advanced Rheumatoid Arthritis via EGFR/JNK/MMP9 Pathway},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {5353--5375},
  doi = {10.2147/ijn.s511421}
}
Kostenlos starten →